-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Aneurysmal subarachnoid hemorrhage is associated with high mortality and morbidity
Vascular prevention
As of February 2020, researchers searched Medline, Web of Science, Embase, Scopus, ProQuest and CochraneCentral
Eligible trials compared the preventive effect of any oral or intravenous drug or intracranial drug-eluting implant, or placebo or standard care in hospitalized patients with confirmed aneurysmal subarachnoid hemorrhage
The researchers included 53 trials involving a total of 10,415 patients
CONCLUSIONS: Nimodipine and cilostazol may be the most effective treatments for preventing morbidity and mortality in patients with aneurysmal subarachnoid hemorrhage
Nimodipine and cilostazol may be the most effective treatments for preventing morbidity and mortality in patients with aneurysmal subarachnoid hemorrhage
Original source:
Mojtaba Dayyani.